首页   按字顺浏览 期刊浏览 卷期浏览 In VitroSusceptibilities of 180 Clinical Isolates ofHaemophilus Influenzaeto Ampicillin...
In VitroSusceptibilities of 180 Clinical Isolates ofHaemophilus Influenzaeto Ampicillin, Amoxycillin/Clavulanate, Cefaclor, Cefuroxime, Cefotaxime, Clarithromycin, and Azithromycin

 

作者: DeludeM.,   CarpentierM.,   GlupczynskiY.,   GordtsB.,   MagermanK.,   SimonA.,   SurmontL.,   Van De VyvereM.,   Van LanduytH.,   NimmenL.Van,   NoyenR.Van,  

 

期刊: Acta Clinica Belgica  (Taylor Available online 1996)
卷期: Volume 51, issue 4  

页码: 237-243

 

ISSN:1784-3286

 

年代: 1996

 

DOI:10.1080/22953337.1996.11718516

 

出版商: Taylor&Francis

 

数据来源: Taylor

 

摘要:

SummaryOne hundred eighty consecutive, unduplicate isolates ofHaemophilus influenzaefrom clinical specimens collected from November 1994 through February 1995 in nine general hospitals throughout Belgium were examined for p-lactamase production using a nitrocefin-based test, and for theirin vitrosusceptibilities to ampicillin, amoxycillin/clavulanate, cefaclor, cefuroxime, cefotaxime, clarithromycin and azithromycin by means of the NCCLS agar dilution test. The isolates were all from respiratory tract specimens. The prevalence of capsular type b was 1.1 %, and the overall rate of p-lactamase production 16.7%. Rates of P-lactamase production were higher in isolates from children (22.0%) than in those from adults (15.3%), and in isolates from upper respiratory tract specimens (22.0%) than in those from the lower resj Piratory tract (15.1%). Beta-lactamase-negative ampicillin resistance amounted to 1.1%. Cefotaxime had the highest activity on a weight basis [MIC (minimal

 

点击下载:  PDF (6388KB)



返 回